Colorectal cancer: Molecules and populations

Journal of the National Cancer Institute

Volumn 91, Issue 11, 1999, Pages 916-932

  Potter, John D ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; ACYLTRANSFERASE; ALCOHOL; ANTINEOPLASTIC AGENT; CELECOXIB; CYTOCHROME P450; FOLIC ACID; HETEROCYCLIC AMINE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; SULINDAC;

ADENOMATOUS POLYP; ALCOHOL CONSUMPTION; CANCER EPIDEMIOLOGY; COLON POLYPOSIS; COLORECTAL CANCER; DIET; DIETARY FIBER; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FAT INTAKE; FRUIT; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HORMONE SUBSTITUTION; HUMAN; MEAT; NUTRITION; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; VEGETABLE;

EID: 0033516320     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.11.916     Document Type: Review

References (238)

1. American Cancer Society (ACS). Cancer facts and figures - 1997. Atlanta (GA): ACS; 1997.
2. World Health Organization (WHO). The world health report. Geneva (Switzerland): WHO; 1997.
3. Parkin DM, Muir CS, Whelan SL, Gao JT, Ferlay J, Powell J. Cancer incidence in five continents. Lyon (France): International Agency for Research on Cancer; 1992.
4. Muir C, Waterhouse J, Mack T, Powell J, Whelan S, Smans M, et al. Cancer incidence in five continents. Lyon (France): International Agency for Research on Cancer; 1987.
5. McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 1980;65:1201-7.
6. Ries LA, Hankey BF, Edwards BK. Cancer statistics review 1973-87. Bethesda (MD): National Institutes of Health, National Cancer Institute; 1990 Report No.: DHHS Publ No. (NIH)90-2789.
7. McMichael AJ, Giles GG. Cancer in migrants to Australia: extending the descriptive epidemiological data. Cancer Res 1988;48:751-6.
8. Haenszel W. Cancer mortality among the foreign born in the United States. J Natl Cancer Inst 1961;26:37-132.
9. Macklin M. Inheritance of cancer of the stomach and large intestine. J Natl Cancer Inst 1960;24:551-71.
10. Veale AM. Intestinal polyposis. Cambridge (U.K.): Cambridge University Press; 1965.
11. Utsunomiya J, Lynch HT. Hereditary colorectal cancer. New York (NY): Springer-Verlag; 1990.
12. Gardner EJ. A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum. Am J Hum Genet 1951;3:167-76.
13. Willett WC. Dietary epidemiology. Oxford (U.K.): Oxford University Press; 1990.
14. World Cancer Research Fund (WCRF) Panel (Potter JD, Chair). Diet, nutrition, and the prevention of cancer: a global perspective. Washington (DC): WCRF/American Institute of Cancer Research; 1997.
15. Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer: a review of the epidemiology. Epidemiol Rev 1993;15:499-545.
16. Steinmetz KA, Potter JD. Vegetables, fruit and cancer prevention: a review. J Am Diet Assoc 1996;96:1027-39.
17. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
18. Singh PN, Fraser GE. Dietary risk factors for colon cancer in a low-risk population. Am J Epidemiol 1998;148:761-74.
19. Giovannucci E, Stampfer MJ, Colditz G, Rimm EB, Willett WC. Relationship of diet to risk of colorectal adenoma in men. J Natl Cancer Inst 1992;84:91-8.
20. Trock B, Lanza E, Greenwald P. Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. J Natl Cancer Inst 1990;82:650-61.
21. Burkitt DP. Related disease - related cause? Lancet 1969;2:1229-31.
22. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Stampfer MJ, Rosner B, et al. Dietary fiber and risk of colorectal cancer and adenoma in women. N Engl J Med 1999;340:169-76.
23. Howe GR, Benito E, Castellato R, Cornee J, Esteve J, Gallagher RP, et al. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J Natl Cancer Inst 1992;84:1887-96.
24. DeCosse JJ, Miller HH, Lesser ML. Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis. J Natl Cancer Inst 1989;81:1290-7.
25. MacLennan R, Macrae F, Bain C, Battistutta D, Chapuis P, Gratten H, et al. Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. The Australian Polyp Prevention Project. J Natl Cancer Inst 1995;87:1760-6.
26. Potter JD. Fiber and colorectal cancer - where to now? N Engl J Med. In press 1999.
27. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control 1991;2:427-42.
28. Freudenheim JL, Graham S, Marshall JR, Haughey BP, Cholewinski S, Wilkinson G. Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 1991;20:368-74.
29. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. Alcohol, low-methionine-low-folate diets and risk of colon cancer in men. J Natl Cancer Inst 1995;87:265-73.
30. Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopoulos D, Rosner BA, et al. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 1993;85:875-84.
31. Slattery ML, Schaffer D, Edwards SL, Ma KN, Potter JD. Are dietary factors involved in DNA methylation associated with colon cancer? Nutr Cancer 1997;28:52-62.
32. Kato I, Akhmedkhanov A, Koenig K, Toniolo PG, Shore RE, Riboli E. Prospective study of diet and female colorectal cancer: the New York University Women's Health Study. Nutr Cancer 1997;28:276-81.
33. Key T, Fraser G, Thorogood M, Appleby P, Beral V, Reeves G, et al. Mortality in vegetarians and non-vegetarians: a collaborative analysis of 8300 deaths among 76,000 men and women in five prospective studies. Public Health Nutr 1998;1:33-41.
34. Gerhardsson de Verdier M, Hagman U, Peters RK, Steineck G, Overvik E. Meat, cooking methods and colorectal cancer: a case-referent study in Stockholm. Int J Cancer 1991;49:520-5.
35. Schiffman MH, Felton JS. Re: "Fried foods and risk of colon cancer" [letter]. Am J Epidemiol 1990;131:376-8.
36. Probst-Hensch NM, Sinha R, Longnecker MP, Witte JS, Ingles SA, Frankl HD, et al. Meat preparation and colorectal adenomas in a large sigmoidoscopy-based case-control study in California (United States). Cancer Causes Control 1997;8:175-83.
37. Slattery ML, Potter JD, Sorenson AW. Age and risk factors for colon cancer (United States and Australia): are there implications for understanding differences in case-control and cohort studies? Cancer Causes Control 1994;5:557-63.
38. Howe GR, Aronson KJ, Benito E, Castelleto R, Cornee J, Duffy S, et al. The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case-control studies. Cancer Causes Control 1997;8:215-28.
39. Giovannucci E, Goldin B. The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. Am J Clin Nutr 1997;66 (6 Suppl):S1564-S1571.
40. Bostick RM, Fosdick L, Wood JR, Grambsch P, Grandits GA, Lillemoe TJ, et al. Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients: a randomized, double-blinded, placebo-controlled clinical trial. J Natl Cancer Inst 1995;87:1307-15.
41. Hyman J, Baron JA, Dain BJ, Sandler RS, Haile RW, Mandel JS, et al. Dietary and supplemental calcium and the recurrence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 1998;7:291-5.
42. Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 1999;340:101-7.
43. Slattery ML, Potter J, Caan B, Edwards S, Coates A, Ma KN, et al. Energy balance and colon cancer - beyond physical activity. Cancer Res 1997; 57:75-80.
44. Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 1995;122:327-34.
45. Bostick RM, Potter JD, Kushi LH, Sellers TA, Steinmetz KA, McKenzie DR, et al. Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 1994;5:38-52.
46. Fraumeni JF Jr, Lloyd W, Smith EM, Wagoner JK. Cancer mortality among nuns: role of marital status in etiology of neoplastic disease in women. J Natl Cancer Inst 1969;42:455-68.
47. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994;7:536-40.
48. Potter JD, Bostick RM, Grandits GA, Fosdick L, Elmer P, Wood J, et al. Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study. Cancer Epidemiol Biomarkers Prev 1996;5: 779-84.
49. Weiss NS, Daling JR, Chow WH. Incidence of cancer of the large bowel in relation to reproductive and hormonal factors. J Natl Cancer Inst 1981; 67:57-60.
50. Potter JD, McMichael AJ. Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study. J Natl Cancer Inst 1983;71:703-9.
51. Wu AH, Paganini-Hill A, Ross RK, Henderson BE. Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. Br J Cancer 1987;55:687-94.
52. Furner SE, Davis FG, Nelson RL, Haenszel W. A case-control study of large bowel cancer and hormone exposure in women. Cancer Res 1989; 49:4936-40.
53. Davis FG, Furner SE, Persky V, Koch M. The influence of parity and exogenous female hormones on the risk of colorectal cancer. Int J Cancer 1989;43:587-90.
54. Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989;44: 833-9.
55. Peters RK, Pike MC, Chang WW, Mack TM. Reproductive factors and colon cancers. Br J Cancer 1990;61:741-8.
56. Wu-Williams AH, Lee M, Whittemore AS, Gallagher RP, Jiao DA, Zheng S, et al. Reproductive factors and colorectal cancer risk among Chinese females. Cancer Res 1991;51:2307-11.
57. Chute CG, Willett WC, Colditz GA, Stampfer MJ, Baron JA, Rosner B, et al. A prospective study of body mass, height, and smoking on the risk of colorectal cancer in women. Cancer Causes Control 1991;2:117-24.
58. Gerhardsson de Verdier M, London S. Reproductive factors, exogenous female hormones, and colorectal cancer by subsite. Cancer Causes Control 1992;3:355-60.
59. Risch HA, Howe GR. Menopausal hormone use and colorectal cancer in Saskatchewan: a record linkage cohort study. Cancer Epidemiol Biomarkers Prev 1995;4:21-8.
60. Jacobs EJ, White E, Weiss NS. Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes Control 1995;5:359-66.
61. Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW Jr. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 1995;87:517-23.
62. Newcomb PA, Storer BE. Postmenopausal hormone use and risk of large bowel cancer [published erratum appears in J Natl Cancer Inst 1995;87: 1416]. J Natl Cancer Inst 1995;87:1067-71.
63. Kampman E, Potter JD, Slattery ML, Caan BJ, Edwards S. Hormone replacement therapy, reproductive history, and colon cancer: a multi-center, case-control study in the United States. Cancer Causes Control 1997;8:146-58.
64. Fernandez E, La Vecchia C, Braga C, Talamini R, Negri E, Parazzini F, et al. Hormone replacement therapy and risk of colon and rectal cancer. Cancer Epidemiol Biomarkers Prev 1998;7:329-33.
65. Jacobson JS, Neugut AI, Garbowski GC, Ahsan H, Waye JD, Treat MR, et al. Reproductive risk factors for colorectal adenomatous polyps (New York City, NY, United States). Cancer Causes Control 1995;6: 513-8.
66. Grodstein F, Martinez ME, Platz EA, Giovannucci E, Colditz GA, Kautzky M, et al. Postmenopausal hormone use and risk of colorectal cancer and adenoma. Ann Intern Med 1998;128:705-12.
67. Woolf C. A genetic study of carcinoma of the large intestine. Am J Hum Genet 1958;10:42-7.
68. Lovett E. Family studies in cancer of the colon and rectum. Br J Surg 1976;63:13-8.
69. Bale SJ, Chakravarti A, Strong LC. Aggregation of colon cancer in family data. Genet Epidemiol 1984;1:53-61.
70. Burt RW, Bishop DT, Cannon LA, Doudle MA, Lee RG, Skolnick MH. Dominant inheritance of adenomatous colonic polyps and colorectal cancer. N Engl J Med 1985;312:1540-4.
71. Carstensen B, Soll-Johanning H, Villadsen E, Sondergaard JO, Lynge E. Familial aggregation of colorectal cancer in the general population. Int J Cancer 1996;68:428-35.
72. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case-control results from the Melbourne Colorectal Cancer Study. Cancer Res 1988;48:4399-404.
73. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 1991;83:355-8.
74. Sun O, Mettlin C, Petrelli NJ. Aspirin use, cancer, and polyps of the large bowel. Cancer 1993;72:1171-7.
75. Peleg II, Maibach HT, Brown SH, Wilcox CM. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med 1994;154:394-9.
76. Muscat JE, Stellman SD, Wynder EL. Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer 1994;74:1847-54.
77. La Vecchia C, Negri E, Franceschi S, Conti E, Montella M, Giacosa A, et al. Aspirin and colorectal cancer. Br J Cancer 1997;76:675-7.
78. Rosenberg L, Louik C, Shapiro S. Nonsteroidal antiinflammatory drug use and reduced risk of large bowel cancer. Cancer 1998;82:2326-33.
79. Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994;5: 138-46.
80. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994;121:241-6.
81. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995;333:609-14.
82. Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-6.
83. Greenberg ER, Baron JA, Freeman DH Jr, Mandel JS, Haile R. Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. J Natl Cancer Inst 1993;85:912-6.
84. Logan RF, Little J, Hawtin PG, Hardcastle JD. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. BMJ 1993;307:285-9.
85. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-6.
86. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Aspirin use and chronic diseases: a cohort study of the elderly. BMJ 1989;299:1247-50.
87. Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 1993;85:1220-4.
88. Stunner T, Glynn RJ, Lee IM, Manson JE, Buring JE, Hennekens CH. Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study. Ann Intern Med 1998;128:713-20.
89. Craven PA, DeRubertis FR. The evolution of cancer of the colon and rectum. Cancer 1992;36:2251-70.
90. Pollard M, Luckert PH. Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors. Cancer Treat Rep 1980;64:1323-7.
91. Narisawa T, Sato M, Tani M, Kudo T, Takahashi T, Goto A. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res 1981;41:1954-7.
92. Moorghen M, Ince P, Finney KJ, Sunter JP, Appleton DR, Watson AJ. A protective effect of sulindac against chemically-induced primary colonie tumours in mice. J Pathol 1988;156:341-7.
93. Reddy BS, Maruyama H, Kelloff G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Cancer Res 1987;47:5340-6.
94. Kawamori T, Rao CV, Seibert K, Reddy BS. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998;58:409-12.
95. Wynder EL, Shigematsu T. Environmental factors of cancer of the colon and rectum. Cancer 1967;20:1520-61.
96. Slattery ML, West DW, Robison LM, French TK, Ford MH, Schuman KL, et al. Tobacco, alcohol, coffee, and caffeine as risk factors for colon cancer in a low-risk population. Epidemiology 1990;1:141-5.
97. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Kearney J, et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst 1994;86: 183-91.
98. Giovannucci E, Colditz GA, Stampfer MJ, Hunter D, Rosner BA, Willett WC, et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst 1994; 86:192-9.
99. Slattery ML, Potter JD, Friedman GD, Ma KN, Edwards S. Tobacco use and colon cancer [published erratum appears in Int J Cancer 1997;71:706]. Int J Cancer 1997;70:259-64.
100. Knekt P, Hakama M, Jarvinen R, Pukkala E, Heliovaara M. Smoking and risk of colorectal cancer. Br J Cancer 1998;78:136-9.
101. Hoff G, Vatn M, Larsen S. Relationship between tobacco smoking and colorectal polyps. Scand J Gastroenterol 1987;22:13-6.
102. Demers RY, Neale AV, Demers P, Deighton K, Scott RO, Dupuis MH, et al. Serum cholesterol and colorectal polyps. J Clin Epidemiol 1988;41: 9-13.
103. Kikendall JW, Bower PE, Burgess MB, Magnetti C, Woodward J, Langenberg P. Cigarettes and alcohol as independent risk factors for colonic adenomas. Gastroenterology 1989;97:660-4.
104. Kono S, Ikeda N, Yanai F, Shinchi K, Imanishi K. Alcoholic beverages and adenomatous polyps of the sigmoid colon: a study of male self-defence officials in Japan. Int J Epidemiol 1990;19:848-52.
105. Zahm SH, Cocco P, Blair A. Tobacco smoking as a risk factor for colon polyps. Am J Public Health 1991;81:846-9.
106. Monnet E, Allemand H, Farina H, Carayon P. Cigarette smoking and the risk of colorectal adenoma in men. Scand J Gastroenterol 1991;26: 758-62.
107. Cope GF, Wyatt JI, Pinder IF, Lee PN, Heatley RV, Kelleher J. Alcohol consumption in patients with colorectal adenomatous polyps. Gut 1991; 32:70-2.
108. Honjo S, Kono S, Shinchi K, Imanishi K, Hirohata T. Cigarette smoking, alcohol use and adenomatous polyps of the sigmoid colon. Jpn J Cancer Res 1992;83:806-11.
109. Olsen J, Kronborg O. Coffee, tobacco and alcohol as risk factors for cancer and adenoma of the large intestine. Int J Epidemiol 1993;22: 398-402.
110. Sandler RS, Lyles CM, McAuliffe C, Woosley JT, Kupper LL. Cigarette smoking, alcohol, and the risk of colorectal adenomas. Gastroenterology 1993;104:1445-51.
111. Lee WC, Neugut AI, Garbowski GC, Forde KA, Treat MR, Waye JD, et al. Cigarettes, alcohol, coffee, and caffeine as risk factors for colorectal adenomatous polyps. Ann Epidemiol 1993;3:239-44.
112. Martinez ME, McPherson RS, Annegers JF, Levin B. Cigarette smoking and alcohol consumption as risk factors for colorectal adenomatous polyps. J Natl Cancer Inst 1995;87:274-9.
113. Potter JD, Bigler J, Fosdick L, Bostick RM, Kampman E, Chen C, et al. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase polymorphisms. Cancer Epidemiol Biomarkers Prev 1999;8:69-75.
114. Stocks P. Cancer incidence in North Wales and Liverpool region in relation to habits and environment. Br Emp Cancer Campaign 35th Annual Report 1957;1:127.
115. Leppert M, Dobbs M, Scrambler P, O'Connell P, Nakamura Y, Stauffer D, et al. The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 1987;238:1411-3.
116. Bodmer WF, Bailey CJ, Bodmer J, Bussey H, Ellis A, Gorman P, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987;328:614-6.
117. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
118. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991;253:665-9.
119. Joslyn G, Carlson M, Thliveris A, Albertsen H, Gelbert L, Samowitz W, et al. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 1991;66:601-13.
120. Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997;17:79-83.
121. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992;359:235-7.
122. Hiltunen MO, Alhonen L, Koistinaho J, Myohanen S, Paakkonen M, Marin S, et al. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int J Cancer 1997;70:644-8.
123. Gardner EJ, Richards RC. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 1953;5:139-47.
124. Hamilton SR, Liu B, Parsons R, Papadopoulos N, Jen J, Powell SM, et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995;332: 839-47.
125. Leppert M, Burt R, Hughes JP, Samowitz W, Nakamura Y, Woodward S, et al. Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med 1990;322:904-8.
126. Spirio L, Olschwang S. Groden J, Robertson M, Samowitz W, Joslyn G, et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell 1993;75:951-7.
127. Gayther SA, Wells D, SenGupta SB, Chapman P, Neale K, Tsioupra K, et al. Regionally clustered APC mutations are associated with a severe phenotype and occur at high frequency in new mutation cases of adenomatous polyposis coli. Hum Mol Genet 1994:3:53-6.
128. Giardiello FM, Petersen GM, Piantadosi S, Gruber SB, Traboulsi EI, Offerhaus GJ, et al. APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis. Gut 1997;40:521-5.
129. Giardiello FM, Krush AJ, Petersen GM, Booker SV, Kerr M, Tong LL, et al. Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology 1994; 106:1542-7.
130. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, et al. Genetic identification of Mom-1, a major modifier locus affecting min-induced intestinal neoplasia in the mouse. Cell 1993;75:631-9.
131. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 1995;81:197-205.
132. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87:803-9.
133. Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 1998;92:645-56.
134. Warthin AS. Heredity with reference to carcinoma. Arch Intern Med 1913;12:546-55.
135. Lynch PM, Lynch HT. Colon cancer genetics. New York (NY): Van Nostrand Rheinhold; 1985.
136. Evans DG, Walsh S, Jeacock J, Robinson C, Hadfield L, Davies DR, et al. Incidence of hereditary non-polyposis colorectal cancer in a population-based study of 1137 consecutive cases of colorectal cancer. Br J Surg 1997;84:1281-5.
137. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998; 338:1481-7.
138. Lynch HT, Lynch JF, Cristofaro G. Genetic epidemiology of colon cancer. In: Lynch HT, Hirayama T, editors. Genetic epidemiology of cancer. Boca Raton (FL): CRC Press; 1989. p. 251-77.
139. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
140. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997;89:1758-62.
141. Sankila R, Aaltonen LA, Jarvinen HJ, Mecklin JP. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 1996;110:682-7.
142. Percesepe A, Benatti P, Roncucci L, Sassatelli R, Fante R, Ganazzi D, et al. Survival analysis in families affected by hereditary non-polyposis colorectal cancer. Int J Cancer 1997;71:373-6.
143. Kolodner RD. Mismatch repair: mechanisms and relationship to cancer susceptibility. Trends Biochem Sci 1995;20:397-401.
144. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-6.
145. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-9.
146. Peltomaki P, Aaltonen LA, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993;260:810-2.
147. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer [published erratum appears in Cell 1994;77:167]. Cell 1993;75:1027-38.
148. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, et al. Mutations of mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.
149. Papadopoulos N, Nicolaides NC, Wei YE, Ruben SM, Carter KC, Rosen CA, et al. Mutation of a mutL homolog in hereditary colon cancer. Science 1994;263:1625-9.
150. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994;368: 258-61.
151. Peltomaki P, de la Chapelle A. Mutations predisposing to hereditary non-polyposis colorectal cancer. Adv Cancer Res 1997;71:93-119.
152. Akiyama Y, Sato H, Yamada T, Nagasaki H, Tsuchiya A, Abe R, et al. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res 1997;57:3920-3.
153. Umar A, Kunkel TA. DNA-replication fidelity, mismatch repair and genome instability in cancer cells. Eur J Biochem 1996;238:297-307.
154. Malkhosyan S, Rampino N, Yamamoto H, Perucho M. Frameshift mutator mutations [letter]. Nature 1996;382:499-500.
155. Thibodeau SN, French AJ, Cunningham JM, Burgart LJ, Roche PC, McDonnell SK, et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 1998;58:1713-8.
156. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997;57:808-11.
157. Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 1998;58:3455-60.
158. Turesky RJ, Lang NP, Butler MA, Teitel CH, Kadlubar FF. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 1991;12:1839-45.
159. Kadlubar FF, Butler MA, Kaderlik KR, Chou HC, Lang NP. Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ Health Perspect 1992;98:69-74.
160. Lang NP, Butler MA, Massengill J, Lawson M, Stotts RC, Hauer-Jensen M, et al. Rapid metabolic phenotypes of acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomarkers Prev 1994;3:675-82.
161. Roberts-Thomson IC, Ryan P, Khoo KK, Hart WJ, McMichael AJ, Butler RN. Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet 1996;347:1372-4.
162. Vineis P, McMichael A. Interplay between heterocyclic amines in cooked meat and metabolic phenotype in the etiology of colon cancer. Cancer Causes Control 1996;7:479-86.
163. Chen J, Stampfer MJ, Hough HL, Garcia-Closas M, Willett WC, Hennekens CH, et al. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res 1998;58:3307-11.
164. Welfare MR, Cooper J, Bassendine MF, Daly AK. Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England. Carcinogenesis 1997;18:1351-4.
165. Kampman E, Slattery ML, Bigler J, Leppert M, Samowitz W, Caan BJ, et al. Meat consumption, genetic susceptibility, and colon cancer risk: a US multi-center case-control study. Cancer Epidemiol Biomarkers Prev. In press 1999.
166. Slattery M, Potter JD, Samowitz W, Bigler J, Caan B, Leppert M. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. In press 1999.
167. Probst-Hensch NM, Haile RW, Ingles SA, Longnecker MP, Han CV, Lin BK, et al. Acetylation polymorphism and prevalence of colorectal adenomas. Cancer Res 1995;55:2017-20.
168. Bell DA, Stephens EA, Castranio T, Umbach DM, Watson M, Deakin M, et al. Polyadenylation polymorphism in the N-acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res 1995;55:3537-42.
169. Probst-Hensch NM, Haile RW, Li DS, Sakamoto GT, Louie AD, Lin BK, et al. Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas. Carcinogenesis 1996;17:2125-9.
170. Lin HJ, Probst-Hensch NM, Hughes NC, Sakamoto GT, Louie AD, Kau IH, et al. Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas. Pharmacogenetics 1998;8:269-81.
171. Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996;56:4862-4.
172. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions and risk of colorectal cancer. Cancer Res 1997;57:1098-102.
173. Grambsch PM, Bostick RM, Grandits G, Fosdick L, Darif M, Potter JD. Modeling the labeling index distribution: an application of functional data analysis. J Am Stat Assoc 1995;90:813-22.
174. Whitehead RH, Jones JK, Gabriel A, Lukies RE. A new colon carcinoma cell line (LIM1863) that grows as organoids with spontaneous differentiation into crypt-like structures in vitro. Cancer Res 1987;47:2683-9.
175. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987;37:147-51.
176. Corpet DE, Stamp D, Medline A, Minkin S, Archer MC, Bruce WR. Promotion of colonic microadenoma growth in mice and rats fed cooked sugar or cooked casein and fat. Cancer Res 1990;50:6955-8.
177. Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994;107: 369-78.
178. Morson BC. The polyp-cancer sequence in the large bowel. Proc R Soc Med 1974;67:451-7.
179. Hill MJ, Morson BC, Bussey HJ. Aetiology of adenoma-carcinoma sequence in large bowel. Lancet 1978;1:245-7.
180. Nathke IS, Adams CL, Polakis P, Sellin JH, Nelson WJ. The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration. J Cell Biol 1996;134:165-79.
181. Barth AI, Nathke IS, Nelson WJ. Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol 1997;9:683-90.
182. Polakis P. The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta 1997;1332:F127-47.
183. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma. Science 1997;275:1784-7.
184. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997;275:1787-90.
185. Peifer M. β-Catenin as oncogene: the smoking gun. Science 1997;275: 1752-3.
186. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281:1509-12.
187. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998; 58:1130-4.
188. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989;244:217-21.
189. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, et al. Allelotype of colorectal carcinomas. Science 1989;244: 207-11.
190. Kinzler KW, Nilbert MC, Vogelstein B, Bryan T, Levy DB, Smith KJ, et al.
191. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990;247:49-56.
192. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
193. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-3.
194. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998;391:184-7.
195. Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998;18:38-43.
196. Dong SM, Kim KM, Kim SY, Shin MS, Na EY, Lee SH, et al. Frequent somatic mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene in left-sided colon cancer. Cancer Res 1998;58:3787-90.
197. Markowitz SD, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995;68:1336-8.
198. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997;75:967-9.
199. Losi L, Ponz de Leon M, Jiricny J, Di Gregorio C, Benatti P, Percesepe A, et al. K-ras and p53 mutations in hereditary non-polyposis colorectal cancers. Int J Cancer 1997;74:94-6.
200. Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Onda A, Okumura Y, et al. Molecular nature of colon tumors in hereditary non-polyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 1996;111:307-17.
201. Wu C, Akiyama Y, Imai K, Miyake S, Nagasaki H, Oto M, et al. DNA alterations in cells from hereditary non-polyposis colorectal cancer patients. Oncogene 1994;9:991-4.
202. Heinen CD, Richardson D, White R, Groden J. Microsatellite instability in colorectal adenocarcinoma cell lines that have full-length adenomatous polyposis coli protein. Cancer Res 1995;55:4797-9.
203. Olschwang S, Hamelin R, Laurent-Puig P, Thuille B, De Rycke Y, Li YJ, et al. Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA 1997;94:12122-7.
204. Huang J, Papadopoulos N, McKinley AJ, Farrington SM, Curtis LJ, Wyllie AH, et al. APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A 1996;93:9049-54.
205. Lynch HT, Lynch PM, Albana WA, Lynch JF. The cancer family syndrome: a status report. Dis Colon Rectum 1981;24:311-22.
206. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998;95:6870-5.
207. Ahuja N, Mohan AL, Li Q, Stolker JM, Herman JG, Hamilton SR, et al. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res 1997;57:3370-4.
208. Myohanen SK, Baylin SB, Herman JG. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res 1998;5 8: 591-3.
209. Brentnall TA. Risk factors for colorectal cancer in inflammatory bowel disease. In: Rutgeerts P, Colombel JF, Hanauer SB, Scholmerich J, Tytgat GN, van Gossum A, editors. Advances in inflammatory bowel diseases. Falk Symposium No. 106. Dordrecht (The Netherlands): Kluwer Academic Publishers; 1999. p. 159-67.
210. Brentnall TA, Crispin DA, Bronner MP, Cherian S, Hueffed M, Rabinovitch PS, et al. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 1996;56:1237-40.
211. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, et al. Mutations of mitotic checkpoint genes in human cancers. Nature 1998; 392:300-3.
212. Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991;51:3075-9.
213. McMichael AJ, Potter JD. Dietary influences upon colon carcinogenesis. In: Hayashi Y, Nagao M, Sugimuta T, Takayama S, Tomatis L, Wattenberg LW, et al, editors. Diet, nutrition and cancer. Proceedings of the 16th International Symposium of the Princess Takamatsu Cancer Research Fund. Tokyo (Japan): Jpn Sci Soc Press; 1986. p. 275-90.
214. Potter JD. Reconciling the epidemiology, physiology, and molecular biology of colon cancer. JAMA 1992;268:1573-7.
215. Wagner C. Biochemical role of folate in cellular metabolism. New York (NY): Marcel Dekker; 1995.
216. Feinberg AP, Vogelstein B. Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun 1983;111:47-54.
217. el-Deiry WS, Nelkin BD, Celano P, Chiu Yen RW, Falco JP, Hamilton SR, et al. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci U S A 1991;88:3470-4.
218. Hoffman RM. Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. A review and synthesis. Biochim Biophys Acta 1984;738:49-87.
219. Yunis JJ, Soreng AL. Constitutive fragile sites and cancer. Science 1984; 226:1199-204.
220. Lengauer C, Kinzler KW, Vogelstein B. DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci U S A 1997;94: 2545-50.
221. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997;386:623-7.
222. Hague A, Paraskeva C. The short-chain fatty acid butyrate induces apoptosis in colorectal tumour cell lines. Eur J Cancer Prev 1995;4:359-64.
223. Wattenberg LW. Inhibition of chemical carcinogenesis. J Natl Cancer Inst 1978;60:11-8.
224. Sugimura T, Sato S. Mutagens-carcinogens in foods. Cancer Res 1983; 43:2415s-2421s.
225. th International Symposium of the Princess Takamatsu Cancer Research Fund. Tokyo (Japan): Jpn Sci Soc Press; 1986. p. 87-96.
226. th International Symposium of the Princess Takamatsu Cancer Research Fund. Tokyo (Japan): Jpn Sci Soc Press; 1986. p. 97-105.
227. Kakiuchi H, Watanabe M, Ushijima T, Toyota M, Imai K, Weisburger J, et al. Specific 5′-GGGA-3′→5′-GGA-3′ mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Proc Natl Acad Sci U S A 1995;92:910-4.
228. Bingham SA, Pignatelli B, Pollock JR, Ellul A, Malaveille C, Gross G, et al. Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer? Carcinogenesis 1996;17:515-23.
229. Kalgutkar AS, Crews BC, Rowlinson SW, Garner C, Seibert K, Marnett LJ. Aspirin-like molecules that covalently inactivate cyclooxygenase-2. Science 1998;280:1268-70.
230. Barnes CJ, Cameron IL, Hardman WE, Lee M. Non-steroidal anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis. Br J Cancer 1998;77:573-80.
231. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, Dubois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells [published erratum appears in Cell 1998;94:following 271]. Cell 1998;93: 705-16.
232. Ruschoff J, Wallinger S, Dietmaier W, Bocker T, Brockhoff G, Hofstadter F, et al. Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc Natl Acad Sci U S A 1998;95:11301-6.
233. Farinati F, Espina N, Lieber CS, Garro AJ. In vivo inhibition by chronic ethanol exposure of methylguanine transferase activity and DNA repair. Ital J Gastroenterol 1985;17:48-9.
234. Garro AJ, Lieber CS. Alcohol and cancer. Annu Rev Pharmacol Toxicol 1990;30:219-49.
235. Potter JD. Hormones and colon cancer [editorial]. J Natl Cancer Inst 1995;87:1039-40.
236. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994;3:687-95.
237. McMichael AJ, Potter JD. Host factors in carcinogenesis: certain bile-acid profiles that selectively increase the risk of proximal colon cancer. J Natl Cancer Inst 1985;75:185-91.
238. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995; 6:164-79.